文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

评估心率、酸中毒、意识、氧合和呼吸频率以预测低氧血症患者的无创通气失败

Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients.
PubMed 文献 · Intensive Care Med · 2016-11-03
一句话结论HACOR量表在无创通气1小时评分>5分可有效预测低氧血症患者NIV失败,高危患者早期插管可能降低院内死亡率。

该研究纳入449例接受无创通气的低氧血症患者作为测试队列,开发了包含心率、酸中毒、意识、氧合和呼吸频率的HACOR量表(最高25分)以预测NIV失败(定义为NIV后需插管),并在358例验证队列中验证。测试队列NIV失败率为47.8%,验证队列为39.4%。NIV失败患者在各时间点的HACOR评分均高于成功者;NIV 1小时以5分为界值,预测NIV失败的敏感度72.6%、特异度90.2%、阳性预测值87.2%、阴性预测值78.1%、诊断准确率81.8%,验证队列证实了这些结果。在NIV 1小时HACOR评分>5分的失败患者中,NIV≤12小时插管者院内死亡率低于较晚插管者[58/88(66%)vs. 138/175(79%);p=0.03]。

要点

  • HACOR量表在NIV 1小时以5分为界值预测NIV失败:敏感度72.6%、特异度90.2%、阳性预测值87.2%、阴性预测值78.1%、诊断准确率81.8%。
  • HACOR评分在NIV开始及1、12、24、48小时,失败患者均高于成功患者。
  • NIV 1小时HACOR评分>5分的失败患者中,NIV≤12小时插管者院内死亡率66%(58/88),晚于12小时插管者79%(138/175),p=0.03。
  • 按诊断、年龄或疾病严重程度分层的亚组中,以及NIV 1、12、24、48小时,HACOR预测NIV失败的诊断准确率均超过80%。
  • HACOR量表变量均可在床旁轻易获取。

适用人群与场景

  • 接受无创通气的低氧血症患者(测试队列449例,验证队列358例)。

诊断标准与关键阈值

  • HACOR量表包含心率、酸中毒、意识、氧合和呼吸频率五个变量,最高25分。
  • NIV 1小时HACOR评分以5分为界值预测NIV失败。
  • NIV失败定义为NIV干预后需插管。

研究设计与关键结果

  • 研究类型为量表开发与验证研究;测试队列449例,验证队列358例。
  • 测试队列NIV失败率47.8%,验证队列39.4%。
  • 测试队列NIV 1小时HACOR预测NIV失败的ROC曲线下面积0.88。
  • NIV 1小时以5分为界值,敏感度72.6%、特异度90.2%、阳性预测值87.2%、阴性预测值78.1%、诊断准确率81.8%,验证队列证实。
  • NIV失败且1小时HACOR>5分的患者中,NIV≤12小时插管者院内死亡率66%(58/88) vs. 晚于12小时插管者79%(138/175),p=0.03。

证据类型、等级与局限

  • 证据类型:量表开发与验证研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为HACOR量表变量易在床旁获取,似乎是预测低氧血症患者NIV失败的有效方法。
  • 作者认为对高危患者早期插管可能降低院内死亡率。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To develop and validate a scale using variables easily obtained at the bedside for prediction of failure of noninvasive ventilation (NIV) in hypoxemic patients.

METHODS: The test cohort comprised 449 patients with hypoxemia who were receiving NIV. This cohort was used to develop a scale that considers heart rate, acidosis, consciousness, oxygenation, and respiratory rate (referred to as the HACOR scale) to predict NIV failure, defined as need for intubation after NIV intervention. The highest possible score was 25 points. To validate the scale, a separate group of 358 hypoxemic patients were enrolled in the validation cohort.

RESULTS: The failure rate of NIV was 47.8 and 39.4% in the test and validation cohorts, respectively. In the test cohort, patients with NIV failure had higher HACOR scores at initiation and after 1, 12, 24, and 48 h of NIV than those with successful NIV. At 1 h of NIV the area under the receiver operating characteristic curve was 0.88, showing good predictive power for NIV failure. Using 5 points as the cutoff value, the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy for NIV failure were 72.6, 90.2, 87.2, 78.1, and 81.8%, respectively. These results were confirmed in the validation cohort. Moreover, the diagnostic accuracy for NIV failure exceeded 80% in subgroups classified by diagnosis, age, or disease severity and also at 1, 12, 24, and 48 h of NIV. Among patients with NIV failure with a HACOR score of >5 at 1 h of NIV, hospital mortality was lower in those who received intubation at ≤12 h of NIV than in those intubated later [58/88 (66%) vs. 138/175 (79%); p = 0.03).

CONCLUSIONS: The HACOR scale variables are easily obtained at the bedside. The scale appears to be an effective way of predicting NIV failure in hypoxemic patients. Early intubation in high-risk patients may reduce hospital mortality.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Duan J, Han X, Bai L, et al. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 2016. PMID: 27812731. doi:10.1007/s00134-016-4601-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。